Teva Won’t Launch Generic Lipitor in US

Teva Pharmaceuticals have decided not to retail atorvastatin, a generic version of Pfizer’s blockbuster cholesterol medication Lipitor, in the US. In December 2011, the Israeli drug maker signed an agreement with Ranbaxy Laboratories to help Ranbaxy during the 180-day exclusivity period they had to sell their copycat version of Lipitor (atorvastatin).  The agreement has resulted

Continue Reading